BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33846816)

  • 1. Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway.
    Zhang YL; Wen XD; Guo X; Huang SQ; Wang TT; Zhou PT; Li W; Zhou LF; Hu YH
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of
    Ma WR; Xu P; Liu ZJ; Zhou J; Gu LK; Zhang J; Deng DJ
    World J Gastroenterol; 2020 Jan; 26(2):184-198. PubMed ID: 31988584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway.
    Jiang F; Chen Y; Ren S; Li Z; Sun K; Xing Y; Zhu Y; Piao D
    Int J Oncol; 2020 Jul; 57(1):183-196. PubMed ID: 32319595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
    Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.
    Wang Y; Xie G; Li M; Du J; Wang M
    PLoS One; 2020; 15(11):e0240106. PubMed ID: 33211699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6.
    Gong T; Li Y; Feng L; Fang M; Dai G; Huang X; Yang Y; Liu S
    Aging (Albany NY); 2020 Jun; 12(12):12086-12106. PubMed ID: 32584787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
    Zhang D; Zhou Q; Huang D; He L; Zhang H; Hu B; Peng H; Ren D
    Biochem Biophys Res Commun; 2019 Jun; 513(3):594-601. PubMed ID: 30981511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptor binding protein 1 correlates with better prognosis and induces caspase-dependent intrinsic apoptosis through the JNK signalling pathway in colorectal cancer.
    Liao Y; Yang Z; Huang J; Chen H; Xiang J; Li S; Chen C; He X; Lin F; Yang Z; Wang J
    Cell Death Dis; 2018 Apr; 9(4):436. PubMed ID: 29567997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
    Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
    Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BEX2 promotes tumor proliferation in colorectal cancer.
    Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
    Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
    Liu YC; Tsai JJ; Weng YS; Hsu FT
    Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
    Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
    Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.